UK markets closed
NIKKEI 225
38,787.38 -132.92 (-0.34%) HANG SENG
19,553.61 +177.11 (+0.91%) CRUDE OIL
80.13 +0.07 (+0.09%) GOLD FUTURES
2,421.90 +4.50 (+0.19%) DOW
40,003.59 +134.19 (+0.34%) Bitcoin GBP
52,216.56 -444.56 (-0.84%)
Cartesian Therapeutics, Inc. (RNAC)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 470.35M |
| Enterprise value | 377.39M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.35 |
| Price/book (mrq) | 31.26 |
| Enterprise value/revenue | 14.57 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -24.05% |
| S&P500 52-week change 3 | 26.49% |
| 52-week high 3 | 42.60 |
| 52-week low 3 | 11.66 |
| 50-day moving average 3 | 19.95 |
| 200-day moving average 3 | 26.30 |
Share statistics
| Avg vol (3-month) 3 | 68.73k |
| Avg vol (10-day) 3 | 66.11k |
| Shares outstanding 5 | 17.8M |
| Implied shares outstanding 6 | 17.8M |
| Float 8 | 3.59M |
| % held by insiders 1 | 60.73% |
| % held by institutions 1 | 11.83% |
| Shares short (30 Apr 2024) 4 | 784.23k |
| Short ratio (30 Apr 2024) 4 | 6.59 |
| Short % of float (30 Apr 2024) 4 | 38.87% |
| Short % of shares outstanding (30 Apr 2024) 4 | 4.41% |
| Shares short (prior month 28 Mar 2024) 4 | 293.11k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:30 |
| Last split date 3 | 05 Apr 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -223.43% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 25.91M |
| Revenue per share (ttm) | 4.94 |
| Quarterly revenue growth (yoy) | -1.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -68.26M |
| Net income avi to common (ttm) | -292.42M |
| Diluted EPS (ttm) | N/A |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 103.42M |
| Total cash per share (mrq) | 5.81 |
| Total debt (mrq) | 10.46M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 3.03 |
| Book value per share (mrq) | N/A |
Cash flow statement
| Operating cash flow (ttm) | -58.31M |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.